GlassScriptPhysician profile
Julie A Lorber
NPI 1225245947
$924.25
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.87 · 2020: $131 · 2021: $54.95 · 2022: $149 · 2023: $157 · 2024: $235 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $252.71 | 2019-2025 | Xifaxan, Trulance |
| Medtronic, INC. | $175.74 | 2021-2025 | Interstim, Gi Genius |
| Medtronic USA, INC. | $116.54 | 2019-2020 | |
| Braintree Laboratories, INC. | $45.65 | 2022-2024 | Suflave |
| Lilly USA, LLC | $45.61 | 2019-2024 | Omvoh |
| Celgene Corporation | $45.45 | 2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $41.62 | 2019-2023 | Entyvio |
| Janssen Biotech, INC. | $36.50 | 2023-2025 | Tremfya, Stelara, Simponi Aria |
| Axonics, INC. | $28.69 | 2020-2023 | Axonics |
| Teleflex LLC | $26.52 | 2024 | Solesta |
| Exact Sciences Corporation | $26.32 | 2025 | The Cologuard Plus Collection Kit |
| Pacira Pharmaceuticals Incorporated | $17.92 | 2024 | Exparel |
| Genzyme Corporation | $16.54 | 2022 | |
| Abbvie INC. | $16.39 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $15.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Lorber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.